Prognostic risk factors in patients with interstitial lung disease referred for lung transplantation

Journal of Physiology and Pharmacology

Volumn 56, Issue SUPPL. 4, 2005, Pages 107-113

  Jastrzebski D ^a   Kozielski, J ^a   Nowak, J ^a   Zielinska Les I ^a   Ziora, D ^a   Szulik, B ^a   Wojarski, J ^a   Zakliczynski M ^a   Zembala, M ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Interstitial lung diseases; Lung transplantation; Prognostic factors

Indexed keywords

ADULT; ARTERIAL OXYGEN TENSION; ARTICLE; CARDIOPULMONARY FUNCTION; CATHETER; CLINICAL ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; FORCED EXPIRATORY VOLUME; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; INTERSTITIAL LUNG DISEASE; LUNG TRANSPLANTATION; MALE; OXYGEN SUPPLY; PATIENT REFERRAL; PROGNOSIS; RESPIRATORY SYSTEM; RISK FACTOR; STATISTICAL SIGNIFICANCE; SURVIVAL RATE;

ADULT; BLOOD GAS ANALYSIS; FEMALE; HEALTH STATUS; HUMANS; KAPLAN-MEIERS ESTIMATE; LUNG DISEASES, INTERSTITIAL; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; OXYGEN; PARTIAL PRESSURE; PROGNOSIS; REFERRAL AND CONSULTATION; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SPIROMETRY; STROKE VOLUME; VENTRICULAR FUNCTION, LEFT; WAITING LISTS; WALKING;

EID: 31344469155     PISSN: 08675910     EISSN: 08675910     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. The registry of the International Society for Heart and Lung Transplantation: an official report, 2004.
2. Zembala M, Wojarski J, Przybylski R et al. First successful heart and lung transplants in Poland - a chance for patients with irreversible damage of these organs. Kardiochir Torakochir Pol 2004; 1: 98-105 (in Polish).
3. International Guidelines for selection of lung transplant candidates. Am J Respir Crit Care Med 1998; 158: 335-339.
4. Douglas W, Ryu J, Schroeder DR. Idiopathic pulmonary fibrosis. Impact of oxygen and colchicine, prednisone or no therapy on survival Am J Respir Crit Care Med 2000; 161: 1172-1178.
5. Timmer SJ, Karamzadeh AM, Yung GL. Predicting survival of lung transplantation candidates with idiopathic interstitial pneumonia. Chest 2002; 122: 779-784.
6. Cahalin LP, Mathier MA, Semigran MJ, Dec GW, DiSalvo TG. The six-minute walk test predicts peak oxygen uptake in patients with advanced heart failure. Chest 1996; 110: 325-332.
7. Enright PL, Sherrill L. Reference equations for six-minute walk in healthy adults. Am J Respir Crit Care Med 1998; 158: 1384-1387.
8. Scholand MB. Clinical approach to interstitial lung disease. Seminars in Ultrasound, CT and MRI 2002; 23: 269-274.
9. Schwartz DA, Helmers RA, Galvin JR et al Determinants of survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1994; 149: 450-454.
10. Erbes R, Schaberg T, Loddenkemper R. Lung function tests in patients with idiopathic pulmonary fibrosis: Are they helpful for predicting outcome? Chest 1997; 111: 51-57.
11. King TE. Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model. Am J Respir Crit Care Med 2001; 164: 1171-1181.
12. Harari S, Simonneau G, De Juli E et al. Prognostic value of pulmonary hypertension in patients with chronic interstitial lung diseases referred for lung or heart-lung transplantation. J Heart Lung Transplant 1997; 16: 460-463.
13. Vizza CD, Yusen RD, Lynch JP, Fedele F, Alexander Patterson G, Trulock EP. Outcome of patients with cystic fibrosis awaiting lung transplantation. Am J Respir Crit Care Med 2000; 162: 819-825.
14. Glanville AR, Estenne M. Indications, patient selection and timing of referral for lung transplantation. Eur Respir Mon 2003; 26: 1-15.
15. Tukiainen P, Taskinen E, Holsti P, Korhola O, Valle M. Prognosis of cryptogenic fibrosing alveolitis. Thorax 1983; 38: 349-355.
16. Bush A, Busst CM. Cardiovascular function at rest and on exercise in patients with cryptogenic fibrosing alveolitis. Thorax 1988; 43: 276-283.